' 
SCIENTIFIC SCORE
Possibly Effective
Based on 6 Researches
7.7
USERS' SCORE
Good
Based on 2 Reviews
8.4
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Lactobacillus acidophilus (La-14)
2 Billion CFU
*
Top Medical Research Studies
9
MENOLACTO alleviates menopausal symptoms
The Effect of YT1 (MENOLACTO) on Improving Menopausal Symptoms: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Relevant and potentially beneficial study
This study explored how MENOLACTO, a form of lactobacillus acidophilus, can help women manage menopausal symptoms. We conducted a rigorous, randomized, double-blinded, placebo-controlled trial with women aged 40 to 60, measuring the effectiveness through various symptom scores and quality of life assessments.
After 12 weeks, we observed a significant decrease in total menopausal symptom scores compared to placebo. Participants also reported improvements across all quality of life metrics. However, we found no notable differences in hormone levels or endometrial thickness between the groups. Overall, MENOLACTO showed promise as a supportive option for alleviating menopause symptoms.
After 12 weeks, we observed a significant decrease in total menopausal symptom scores compared to placebo. Participants also reported improvements across all quality of life metrics. However, we found no notable differences in hormone levels or endometrial thickness between the groups. Overall, MENOLACTO showed promise as a supportive option for alleviating menopause symptoms.
Read More
9
Lactobacillus improves vaginal health
Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
High relevance due to safety
We explored how a combination of ultra-low-dose estriol and lactobacillus in vaginal tablets affects vaginal health in postmenopausal breast cancer survivors taking aromatase inhibitors. Over 28 days, participants showed notable improvements in vaginal microflora and reduced inflammatory markers.
Improvements included higher lactobacillary grades and lower incidences of aerobic vaginitis and leukocytes, which were significant (p < 0.001 for many observations). Although we saw a temporary increase in Candida colonization initially, it quickly returned to baseline. Overall, this combination appears effective and safe for managing severe vaginal issues in this population.
Improvements included higher lactobacillary grades and lower incidences of aerobic vaginitis and leukocytes, which were significant (p < 0.001 for many observations). Although we saw a temporary increase in Candida colonization initially, it quickly returned to baseline. Overall, this combination appears effective and safe for managing severe vaginal issues in this population.
Read More
9
Lactobacillus and estriol resolved vaginal atrophy
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Relevance score indicates study's importance
We focused on how Lactobacillus acidophilus, combined with ultra-low-dose estriol, affects vaginal atrophy in postmenopausal women undergoing treatment for breast cancer.
In our study, 16 women used a daily vaginal tablet for 28 days and continued with a weekly maintenance schedule.
While estriol levels showed a small, temporary increase, estrogen levels did not rise significantly. Most importantly, vaginal atrophy improved for all participants, and they tolerated the treatment well.
In our study, 16 women used a daily vaginal tablet for 28 days and continued with a weekly maintenance schedule.
While estriol levels showed a small, temporary increase, estrogen levels did not rise significantly. Most importantly, vaginal atrophy improved for all participants, and they tolerated the treatment well.
Read More
Most Useful Reviews
8.8
Feeling better
I have felt improvement since switching to this royal jelly. Five years ago, I became ill and suspect it might be menopause. After trying various treatments without success, I found this royal jelly has helped me feel naturally sleepy at night and more energised during the day. Though I still experience hot flashes, my anxiety has decreased, and my mental state feels more stable. I want to continue using it, but I’m devastated that sales seem to have ended.
Read More
6.8
Improved digestion
During menopause, I experienced constipation, but since taking this supplement every morning, I’ve found it has greatly helped. I have tried Acidophilus from other brands, but this one suits me better.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 6 Researches
7.7
- All Researches
9
MENOLACTO alleviates menopausal symptoms
The Effect of YT1 (MENOLACTO) on Improving Menopausal Symptoms: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
Relevant and potentially beneficial study
This study explored how MENOLACTO, a form of lactobacillus acidophilus, can help women manage menopausal symptoms. We conducted a rigorous, randomized, double-blinded, placebo-controlled trial with women aged 40 to 60, measuring the effectiveness through various symptom scores and quality of life assessments.
After 12 weeks, we observed a significant decrease in total menopausal symptom scores compared to placebo. Participants also reported improvements across all quality of life metrics. However, we found no notable differences in hormone levels or endometrial thickness between the groups. Overall, MENOLACTO showed promise as a supportive option for alleviating menopause symptoms.
After 12 weeks, we observed a significant decrease in total menopausal symptom scores compared to placebo. Participants also reported improvements across all quality of life metrics. However, we found no notable differences in hormone levels or endometrial thickness between the groups. Overall, MENOLACTO showed promise as a supportive option for alleviating menopause symptoms.
Read More
9
Lactobacillus improves vaginal health
Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
High relevance due to safety
We explored how a combination of ultra-low-dose estriol and lactobacillus in vaginal tablets affects vaginal health in postmenopausal breast cancer survivors taking aromatase inhibitors. Over 28 days, participants showed notable improvements in vaginal microflora and reduced inflammatory markers.
Improvements included higher lactobacillary grades and lower incidences of aerobic vaginitis and leukocytes, which were significant (p < 0.001 for many observations). Although we saw a temporary increase in Candida colonization initially, it quickly returned to baseline. Overall, this combination appears effective and safe for managing severe vaginal issues in this population.
Improvements included higher lactobacillary grades and lower incidences of aerobic vaginitis and leukocytes, which were significant (p < 0.001 for many observations). Although we saw a temporary increase in Candida colonization initially, it quickly returned to baseline. Overall, this combination appears effective and safe for managing severe vaginal issues in this population.
Read More
9
Lactobacillus and estriol resolved vaginal atrophy
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Relevance score indicates study's importance
We focused on how Lactobacillus acidophilus, combined with ultra-low-dose estriol, affects vaginal atrophy in postmenopausal women undergoing treatment for breast cancer.
In our study, 16 women used a daily vaginal tablet for 28 days and continued with a weekly maintenance schedule.
While estriol levels showed a small, temporary increase, estrogen levels did not rise significantly. Most importantly, vaginal atrophy improved for all participants, and they tolerated the treatment well.
In our study, 16 women used a daily vaginal tablet for 28 days and continued with a weekly maintenance schedule.
While estriol levels showed a small, temporary increase, estrogen levels did not rise significantly. Most importantly, vaginal atrophy improved for all participants, and they tolerated the treatment well.
Read More
9
Effective combination therapy for menopause
Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy.
High relevance based on findings.
We examined the effectiveness of an ultra-low-dose vaginal estriol combined with Lactobacillus acidophilus to treat vaginal atrophy in postmenopausal women. This well-structured double-blind, randomized study showed that after just 12 days of treatment, those using the combination saw a significant improvement in their Vaginal Maturation Index compared to those on a placebo.
Even in the long term, maintenance therapy proved effective in keeping symptoms at bay. Our findings indicate that this combination therapy can positively impact vaginal health during menopause, enhancing comfort and wellness.
Even in the long term, maintenance therapy proved effective in keeping symptoms at bay. Our findings indicate that this combination therapy can positively impact vaginal health during menopause, enhancing comfort and wellness.
Read More
8
Combination therapy shows benefits
Treatment of vaginal atrophy with estriol and lactobacilli combination: a clinical review.
High relevance for menopause treatment
We explored how a unique treatment combining a low dose of estriol and Lactobacillus acidophilus benefits menopausal women experiencing vaginal atrophy. This combination therapy works by promoting vaginal health and restoring natural flora, significantly improving symptoms and quality of life.
Additionally, it boasts a good safety profile, with few side effects and minimal estriol absorption. Overall, this evidence suggests that such combination therapy is a promising option for managing symptoms of vaginal atrophy during menopause.
Additionally, it boasts a good safety profile, with few side effects and minimal estriol absorption. Overall, this evidence suggests that such combination therapy is a promising option for managing symptoms of vaginal atrophy during menopause.
Read More
User Reviews
USERS' SCORE
Good
Based on 2 Reviews
8.4
- All Reviews
- Positive Reviews
- Negative Reviews
8.8
Feeling better
I have felt improvement since switching to this royal jelly. Five years ago, I became ill and suspect it might be menopause. After trying various treatments without success, I found this royal jelly has helped me feel naturally sleepy at night and more energised during the day. Though I still experience hot flashes, my anxiety has decreased, and my mental state feels more stable. I want to continue using it, but I’m devastated that sales seem to have ended.
Read More
6.8
Improved digestion
During menopause, I experienced constipation, but since taking this supplement every morning, I’ve found it has greatly helped. I have tried Acidophilus from other brands, but this one suits me better.
